What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Oct 4, 2022
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Brian Feagan, Christopher Ma, Claire E Parker, Geert D’Haens, Niels Vande Casteele, Stefanie C McFarlane, Vipul Jairath

Publication Sep 1, 2022
Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn’s Disease

Brian Feagan, Christopher Ma, Lisa M Shackelton, Vipul Jairath

Publication Jul 16, 2022
Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization

Eileen Crowley, Vipul Jairath

Publication Jul 3, 2022
Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis

Christopher Ma, Rocio Sedano, Vipul Jairath

Publication Jun 24, 2022
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease: Meta-Analysis of Randomised Controlled Trials

Brian Feagan, Christopher Ma, Claire E Parker, Eileen Crowley, Geert D’Haens, Guangyong Zou, Malcolm Hogan, Rocio Sedano, Vipul Jairath

Publication Jun 24, 2022
Comparison of the Relative Sensitivity of Clinical, Endoscopic, and Histologic Remission for Detection of Treatment Efficacy in Ulcerative Colitis Trials

Brian Feagan, Christopher Ma, Guangyong Zou, Malcolm Hogan, Rocio Sedano, Vipul Jairath